Oncolytics Biotech (ONCY) Depreciation & Amortization - Total (2024 - 2025)
Oncolytics Biotech (ONCY) posted quarterly Depreciation & Amortization - Total of $17.44 for Q3 2025, down 33.92% year-over-year from $26.39 in Q3 2024, and down 33.92% quarter-over-quarter from $26.39 in Q3 2024.
Oncolytics Biotech (ONCY) Depreciation & Amortization - Total (2024 - 2025) Analysis & Trends
Oncolytics Biotech (ONCY) has reported Depreciation & Amortization - Total for 2 consecutive years, with $17.44 the latest figure, recorded in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Oncolytics Biotech | 101.16 Mn | 101.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 17.44 |
| Sep 30, 2024 | 26.39 |